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DIABETIC retinopathy is a common cause ofblindness. The introduction ofphoto-
coagulation treatment has stimulated interest in this condition and several well
designed and properly controlled studies have shown that either xenon arc or argon
laser photocoagulation therapy can arrest or delay the progression of diabetic
retinopathy.1-7 This treatment is now available at many centres in the UK, and the
time has come to assess its impact on the overall expectation for vision in diabetics.
This paper reports the natural history ofvisual acuity in a selected group ofdiabetic
patients observed for at least five years. Photocoagulation therapy was performed
when indicated, as were other specific ophthalmic procedures.
PATIENTS AND METHODS
The combined Diabetic/Eye Clinic at the Royal Victoria Hospital, Belfast, was
established in 1972 as a referral centre for diabetic patients with ophthalmic disease
in Northern Ireland. Patients have been referred to this clinic in several ways. The
majority were routine referrals from the Diabetic Clinic at the Royal Victoria
Hospital, for detailed fundus examination, photographic documentation and
fluorescein angiography. Only those patients who had diabetes for more than 10
years are included in this particular study. Patients from the RVH or other hospital
diabetic clinics and occasionally from family doctors were also referred for specific
ophthalmic reasons, e.g., loss of vision. Consultant ophthalmologists in other
hospitals have also referred patients for specialist advice and treatment-these
tended to be only the more severe cases.
Visual functions were recorded and detailed ophthalmological examination
undertaken after dilatation of the pupils (phenylephrine 10 per cent, cyclopentolate
1 per cent) at each visit. Fluorescein angiography was performed if necessary. The
ocular fundi were photographically documented (standard fields). The retinal
appearances were classified as "no retinopathy", "background retinopathy"
(microaneurysms, haemorrhages and exudates without macular involvement) and
"severe retinopathy" (proliferative vasculopathy or exudative maculopathy). The
best corrected visual acuity using a Snellen chart was recorded at each visit by
trained nursing personnel under medical supervision. Argon laser photocoagulation
treatment was given for proliferative vasculopathy, either directly to new vessel
formations if remote from the mascula or optic disc, or indirectly by more
generalised retinal ablation, especially in optic disc proliferation. In exudative
maculopathy direct treatment was given to microvascular abnormalities associated
with exudative lesions at the posterior pole, identified by fluorescein angiography or
seen at the centre of circinate patterns.
139Data on blood glucose control during the entire diabetic history of each patient
was not available, as many had come from other hospitals. For those for whom
complete or nearly complete documentation of two hour postprandial venous blood
glucose values were available from the onset of diabetes, it was possible to calculate
a mean and standard deviation of blood glucose for each patient. This was possible
in view of the relatively large number of observations: it has been the practice in
several clinics in Northern Ireland to measure postprandial venous blood glucose in
diabetic patients for many years.
RESULTS
Between 1972 and 1979 we examined 1157 patients at the Diabetic Eye Clinic.
Fifty-two of these patients died before 1979 and 79 are no longer attending the
Clinic, 1026 patients remain under regular review. The life expectancy of these
TABLE I
Diabetic Eye Clinic, Royal Victoria Hospital, Belfast
Patients attending November 1972-August 1979
Still Not Photocoagulation
Attending Attending Died treatment
Severe Retinopathy 145 28 28 142
Background Retinopathy 453 18 15 126
No Retinopathy 401 33 6
Others/unclassified 27 0 3 4
1026 79 52 272
TABLE II
Classification on Ophthalmic Assessment:
Patients observed over S years
Mean Age at Mean Duration Therapy
Classification ofDiabetes Insulin Diet/OHA
(±SD) (±SD) % %
Severe retinopathy 47 ± 15 18 ± 7 83 17
(40 patients)
Background retinopathy 55 ± 14 16 ± 12 76 24
(33 patients)
No retinopathy 42 ± 17 12 ± 10 81 19
(32 patients)
OHA-Oral hypoglycaemic agent.
140patients has been analysed separately.8 Two hundred and seventy two patients have
received photocoagulation treatments between November 1972 and August 1979
(Table I). We have now continued observation of 105 of these patients for at least
five years. The ophthalmological classification in this subgroup at the initial
examination showed no retinopathy in 32, simple background retinopathy in 33 and
severe retinopathy in 40 (Table II). The mean age and mean duration ofdiabetes at
classification were not significantly different. The great majority ofpatients were on
insulin treatment. Blood glucose data was available for 23 of the no retinopathy
group, 21 of the background retinopathy group and 27 of the severe retinopathy
group, who had attended the RVH diabetic clinic.
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Figure 1. Initial visual acuity on vertical axis: Visual acuity at S years on
horizontal axis. Each circle or triangle represents one eye. Open circles indicateeyes
photocoagulated. Numbers indicate numbers ofeyes. Diagonal line represents no
change in visual acuity over S years.
CF =counting fingers HM =hand movements
PL =perception of light NPL = no perception of light
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Figure 2. Initial visual acuity on vertical axis: Visual acuity at 5 years on
horizontalaxis. Each circle or triangle represents one eye. Open circles indicate eyes
photocoagulated. Numbers indicate numbers of eyes. Diagonal line represents no
change in visual acuity over 5 years.
CF =counting fingers HM =hand movements
PL =perception of light NPL = no perception of light
TABLE III
5 YearPrognosisfor Vision: IndividualEyes
(a change of2 lines in the Snellen chart was necessaryfor change in visual assessment)
Visual Severe Background No
Assessment Retinopathy Retinopathy Retinopathy
Same 25 (31%) 43 (65%) 55 (86/o)
Better 10 (13%) 5 (8%) 4 (6%)
Worse 45 (56Gb) 18 (27%) 5 (8%)
80 66 64
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S D .The visual acuity at the initial assessment compared to that at five years later for
the three subgroups is plotted in Figures 1, 2 and 3 and analysed in Table III.
Considering individual eyes there were 64 with no retinopathy, 66 with background
retinopathy and 80 with severe retinopathy (Table III). Visual acuity deteriorated
over the five years in five eyes (8 per cent) that were initially classified as no
retinopathy due to the development of cataracts. In the background retinopathy
group visual acuity deteriorated in 18 (27 per cent) of the eyes-in the majority due
to the development of macular exudates, only a few eyes developing new vessels.
Forty-three (65 per cent) of eyes initially classified as background retinopathy
remained unchanged over five years. In the severe retinopathy group visual acuity
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Figure 3. Initial visual acuity on vertical axis: Visual acuity at 5 years on
horizontal axis. Each circle or triangle represents one eye. Open circles indicate eyes
photocoagulated. Numbers indicate numbers of eyes. Diagonal line represents no
change in visual acuity over S years.
CF =counting fingers HM = hand movements
PL =perception of light NPL = no perception of light
143TABLE IV
Risk Factorsfor Visual Deterioration in Severe Retinopathy
Poor visual acuity
(<6/60) at year 0
Deterioration in
visual acuity to
<16/60 in 5 years
No change in
visual acuity
(>16/60) over 5
years
Age
(+SD)
53 (±+13.2)
44.4 (±15.2)
44.4 (±+14.5)
Duration of
Diabetes
(+SD)
17.5 (+9.8)
16.4 (±7.9)
18.7 (±3.1)
Therapy
Insulin OHA BP
No N% Mean
58 42 153/90
88 12 139/87
86 14 141/79
OHA-Oral hypoglycaemic agent.
TABLE V
Relation of2-3 hourpostprandial venous blood glucose levels in the long term
to thepresence ofdiabetic retinopathy
No
Retinopathy
Number
Age at onset
Present age
Duration of diabetes
Mean total number of recorded
blood glucose per patient
Average number of blood glucose
per year of follow up
33
32
47
15
70
6
Background
21
28
46
19
102
6
Severe
27
35
54
20
69
4
Mean recorded blood glucose
(-SD) since first attendance mmol/1
9.4 + 4.8 10.1 + 5.4 10.1 + 4.8
deteriorated in 45 eyes (56 per cent) over five years, remained unchanged in 25 (31
per cent) and improved in 10 (13 per cent). Extensive neovascularization and its
sequelae was responsible for deterioration in the majority of the severe retinopathy
group. A change of two lines on the Snellen chart in the five years was necessary for
this analysis. Seven eyes (11 per cent) received argon laser photocoagulation therapy
in the "background" group, 38 (48 per cent) in the "severe" group.
144Age, and duration of diabetes, or the need for insulin therapy were not different
in those patients whose vision deteriorated (Table IV). The mean blood pressure in
those patients whose vision deteriorated was not significantly different from those
whose vision did not change. For the patients for whom documentation of
outpatient blood glucose values was possible, the mean + standard deviation of the
recorded 2 hour postprandial blood glucose values are shown in Table V. The mean
ages and duration of diabetes for these subgroups are somewhat different from
those of the complete data. An average of between 69 and 102 blood glucose values
were available for these three subgroups, obtained at routine outpatient reviews-
this gave an average of four to six values annually. The mean recorded blood glucose
from the time of first diagnosis for those in the no retinopathy group was 9.4
mmol/l, for the background retinopathy group 10.0 mmol/l and for the severe
retinopathy group 10.0 mmol/l.
DISCUSSION
The prognosis for vision in diabetics with established severe retinopathy is poor,
but has improved since the introduction of photocoagulation treatment. Several
trials 14 have demonstrated the effectiveness of this therapy in modifying the
progress of proliferative retinopathy and exudative maculopathy. There was no
difference in antidiabetic therapy or duration of diabetes in our patients whose
vision deteriorated compared with those whose vision remained unchanges or
improved.
In the absence of a fully prospective study of the development of retinopathy in
relation to blood glucose control, it is relevant to observe even the partial
documentation which is available in our hospital records. The tradition of
measuring outpatient 2-3 hour postprandial venous blood glucose values under
supervision has continued for many years in Northern Ireland, and we feel that the
incomplete data presented in Table V at least merits inspection. None of the three
groups achieved what might be called good control of their observed blood glucose
values, but equally, those with the severe retinopathy did not have the highest mean
blood glucose value. The studies of Job et al9 and Ashikaga et al'0 have not resolved
the question of whether or not diabetic control affects the development or progress
of retinopathy."' 12
Coagulation abnormalities secondary to the abnormal metabolic state in diabetes
may be a factor in diabetic retinopathy.'3' 14 The elevated levels of glycosylated
haemoglobins found in diabetics with 'bad' control"5 may be associated with tissue
hypoxia. 16 In an associated study in Belfast Elder et al1' did not confirm the presence
of a hypercoagulable state in diabetic patients with retinopathy. Rather than a
specific or primary increase in one of the many coagulation factors, they found a
generalised increase in both coagulation and fibrinolytic elements of the blood
clotting mechanism, and felt that these changes were more likely to be secondary to
the presence of microvascular disease.
Smoking may be a risk factor for proliferative retinopathy,'7 but we did not
investigate this in detail. A greater prevalence of visual deterioration was found
among non-smokers in this study, but there may be many reasons for this
unexpected finding. The assessment of smoking habits was by simple verbal
145questioning at non-standardised times, and it is recognised that as vision
deteriorates, many smokers tend to discontinue the habit.
If it is accepted that early detection and treatment of diabetic retinopathy can
arrest deterioration of visual acuity, consideration must be given to the staffing of
specialised diabetic ophthalmic clinics. From the data at the RVH diabetic clinic of
2200 patients it is estimated that there are about 30 patients with 'severe' retinopathy
per 1000 patients attending. Donovan18 had found a much higher prevalence of 11.6
per cent 'severe' retinopathy in patients attending a diabetic clinic at a district
general hospital. The relatively inefficient fundus examination possible through
undilated pupils at a diabetic clinic may pick up early retinal disease, but our policy
is to obtain detailed ophthalmological examinations in all insulin-requiring diabetics
of 10 years duration or where patients present at any time with symptoms of
disturbed vision. Only detailed examination of this type can allow accurate
assessment of clinical severity.
SUMMARY AND CONCLUSIONS
A group of 105 diabetic patients, 32 of whom had no detectable retinopathy, 33
simple background retinopathy and 40 of whom had severe retinopathy were
observed over five years with specialist ophthalmic supervision. In 146 eyes with
retinopathy 68 (46.6 per cent) remained unchanged, 61 (41.8 per cent) deteriorated
and 17 (11.6 per cent) improved during the five years; those graded as severe
retinopathy at initial assessment deteriorated most. Age and duration ofdiabetes, or
the need for insulin therapy were not different in those patients whose vision
deteriorated. Hypertension was rare. Assessment of available recorded blood
glucose values in some of these patients suggested that ideal control of the blood
glucose had not been achieved in any ofthe three groups classified by severity of the
retinopathy: neither did those with the most severe retinopathy have the highest
mean recorded blood glucose values.
The five year prognosis for vision in this diabetic population was relatively good.
Only a small proportion ofdiabetics develop severe retinopathy. Vision in this group
may deteriorate in spite of photocoagulation treatment.
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